Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

January 17, 2026

When Should You Go to the Hospital for a Urinary Tract Infection (UTI)?

  • Multiple Sclerosis (MS) Symptoms
    /
Urine that’s unexpectedly bloody warrants a trip to the hospital or emergency room. Flu-like symptoms may also be a sign…
Multiple Sclerosis (MS) Symptoms

January 16, 2026

Fat composition in ketogenic diet may influence outcomes in MS

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
  • Nutrition
    /
Diet failed to reduce optic nerve damage in mouse model Written by Steve Bryson, PhD |  A ketogenic diet — a very…
Multiple Sclerosis

January 16, 2026

What is Acthar Gel (repository corticotropin injection)

  • MS Relapse
    /
  • MS Relapse-Exacerbation
    /
  • Multiple Sclerosis
    /
Acthar Gel is indicated for: Understand more about Acthar Gel, by clicking here…
MS Relapse

January 16, 2026

What is Purified Cortrophin Gel?

  • MS Relapse
    /
  • MS Relapse-Exacerbation
    /
Purified Cortrophin Gel is a prescription medicine that is injected under the skin or into the muscle. It is used…
MS Relapse

January 15, 2026

Immune Signal Ratio May Predict Progressive Multiple Sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
January 2, 2026 Summary: A long-term study has identified a potential biomarker that could help detect which patients are progressing toward…
MS Drug Therapies

January 14, 2026

Multiomics integration prioritizes potential drug targets for multiple sclerosis

  • MS Research Study and Reports
    /
Significance We tested hundreds of multiple sclerosis (MS)-associated proteins in plasma and brain and confirmed the potential causal role of…
MS Research Study and Reports

January 6, 2026

Natalizumab (natalizumab-sztn) now recommended in England to treat hard-to-control MS

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
NICE decision will allow NHS coverage of Tysabri, Tyruko for relapsing-remitting MS Written by Marisa Wexler, MS | January 6, 2026 The National…
MS Drug Therapies

January 2, 2026

Perceived Pain during Isometric Exercise and Neuromuscular Fatigability in Individuals with Multiple Sclerosis

  • MS Pain and Side Effects
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Oct 2025 Highlights • How pain during exercise relates to neuromuscular fatigability in MS is unclear • Smaller changes in…
MS Pain and Side Effects

December 25, 2025

Four distinct paths of disability progression emerge in relapsing MS

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Findings may help explain why symptoms worsen even without relapses Written by Marisa Wexler, MS | December 24, 2025 Disability progression in relapsing…
MS Research Study and Reports

December 25, 2025

Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food…
MS Research Study and Reports

Categories

Latest Blog Posts